ASTRAZENECA PHARMA INDIA
Back to Cashflow Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-66 Cr | ₹-44 Cr | ₹-24 Cr | ₹-9.46 Cr | ₹-8.97 Cr |
What is the latest Cash Flow from Financing Activities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-66 Cr |
| Mar2024 | ₹-44 Cr |
| Mar2023 | ₹-24 Cr |
| Mar2022 | ₹-9.46 Cr |
| Mar2021 | ₹-8.97 Cr |
How is Cash Flow from Financing Activities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-66 Cr | Negative | |
| Mar2024 | ₹-44 Cr | Negative | |
| Mar2023 | ₹-24 Cr | Negative | |
| Mar2022 | ₹-9.46 Cr | Negative | |
| Mar2021 | ₹-8.97 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹19,440.3 Cr | 0.2% | -10.6% | -9.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | 0.2% |
-10.6% |
-9.7% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses